Platform

Flexitab™ Technology

A new extended-release platform with novel differentiating features

Breakable Alcohol Insensitive Extended-Release Platform

Enables extended-release tablets that are breakable with no loss of performance for 

  • Precise, accurate breaking
  • Safer to Use tablets – no dose dumping
  • Multiple dosing options from a single tablet 
  • Simple and smooth titration and tapering
  • Greater flexibility for better compliance 
  • Individualized patient care

Enabled by our AmyloFlex™ excipient

A unique self-forming membrane technology

AmyloFlex™ proprietary excipient is a complex starch modified-release technology

Comprised of amylose and amylopectin

  • Patent protected until 2038
  • Regulatory compliant
  • Stable under warehouse conditions
  • Simply & cost-effectively manufactured 
  • Safe & clinically validated

Flexitab™: a range of clinical and value added benefits beyond titration